29(2 Suppl): S126S131.CrossRefGoogle ScholarPubMed Lindenbaum, J, Healton, E, Savage, D
Going beyond 500mcg rarely provides additional benefit and may increase the likelihood of mild side effects like headaches or injection site reactions
This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
The systematic review of various evidence and studies suggests that a higher dietary intake of B vitamins could lower the risk of advanced macular degeneration
Cohort 2 consisted of patients (not in cohort 1) who received 6 or more intramuscular injections within 1 year and had a laboratory test 2 months before the intramuscular injection claim
Available studies conducted predominantly on animal models indicate that 5-amino-1MQ is orally active in rats